Status not kept up to date
Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage
NCT02924597 · RenJi Hospital · Updated 5 Oct 2016
- What is being tested
- zero ischemia robot-assisted laparoscopic RFA assisted TE; zero ischemia robot-assisted laparoscopic partial nephrectomy
- For
- Renal Cell Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 15 years to 80 years. About 100 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started Jan 2016, ends Aug 2018. Registered 5 Oct 2016.
- Results
- None posted yet.
In the researchers' words
To evaluate the feasibility and efficiency of zero ischemia robot-assisted laparoscopic radio frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with robot-assisted laparoscopic partial nephrectomy without hilar clamping.
Sites
- Ethics Committee of Shanghai Renji HospitalShanghai, Shanghai Municipality, China